A febrile neutropenic patient with Enterococcus gallinarum sepsis treated with daptomycin and gentamicin

Pharmacotherapy

Volumn 27, Issue 6, 2007, Pages 927-932

  Barber, Gerard R ^a   Lauretta, Joseph ^b   Saez, Ruben ^c  

^a UNIVERSITY OF COLORADO HOSPITAL   (United States)

^b LAKELAND REGIONAL MEDICAL CENTER   (United States)

^c Watson Clinic   (United States)

Author keywords

Bacteremia; Daptomycin; Enterococci; Enterococcus; Enterococcus gallinarum; Intrinsic drug resistance; Vancomycin resistant enterococci

Indexed keywords

CARBOPLATIN; CEFEPIME; DAPTOMYCIN; DOCETAXEL; DOCUSATE SODIUM; GENTAMICIN; LEVOFLOXACIN; LORAZEPAM; METOCLOPRAMIDE; MORPHINE SULFATE; POTASSIUM CHLORIDE; QUETIAPINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VANCOMYCIN;

ABDOMINAL PAIN; ADULT; ANXIETY DISORDER; ARTICLE; BACKACHE; BACTEREMIA; BIPOLAR DISORDER; BLOOD CULTURE; CARCINOMATOUS PERITONITIS; CASE REPORT; COMBINATION CHEMOTHERAPY; ENTEROCOCCUS GALLINARUM; FEBRILE NEUTROPENIA; FEMALE; HUMAN; LAPAROTOMY; LOADING DRUG DOSE; LOWER RESPIRATORY TRACT INFECTION; PEPTIC ULCER; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; SEPSIS; SIDE EFFECT; STOMACH BYPASS; THORAX PAIN;

ANTI-BACTERIAL AGENTS; BACTEREMIA; CATHETERS, INDWELLING; CROSS INFECTION; DAPTOMYCIN; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY, COMBINATION; ENTEROCOCCUS; FEMALE; FEVER; GENTAMICINS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NEUTROPENIA;

EID: 34249807343     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.27.6.927     Document Type: Article

References (21)

1. National Nosocomial Infections Surveillance (NNIS) System. National nosocomial infections surveillance (NNIS) system report, data summary from January 1992-April 2000. Am J Infect Control 2000;28:429-48.
2. Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004;39:309-17.
3. Chow JW, Rice LB, Muder RR. Enterococcus species. In: Yu VL, Weber R, Raoult D, eds. Antimicrobial therapy and vaccines, 2nd ed. New York: Apple Trees Productions, 2002:265-80.
4. Piper KE, Steckelberg JM, Patel R. In vitro activity of daptomycin against clinical isolates of gram-positive bacteria. J Infect Chemother 2005;11:207-9.
5. LeClercq R, Bingen E, Su QH, Lambert-Zechovsky N, Courvalin P, Duval J. Effects of β-lactams, daptomycin, gentamicin, and glycopeptides against glycopeptide-resistant enterococci. Antimicrob Agents Chemother 1991;35:92-8.
6. Mellman RL, Spisak GM, Burakoff R. Enterococcus avium bacteremia in association with ulcerative colitis. Am J Gast 1992;87:337-8.
7. Van Goethem GF, Louwagie BM, Simoens MJ, Vandeven JM, Verhaegen JL, Boogaerts MA. Enterococcus casseliflavus septicaemia in a patient with acute myeloid leukaemia. Eur J Clin Microbiol Infect Dis 1994;13:519-20.
8. Hsueh PR, Teng LJ, Chen YC, Yang PC, Ho SW, Luh KT. Recurrent bacteremic peritonitis caused by Enterococcus cecorum in a patient with liver cirrhosis. J Clin Microbiol 2000;38:2450-2.
9. Gordon S, Swenson JM, Hill BC, et al, for the Enterococcal Study Group. Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. J Clin Microbiol 1992;30:2373-8.
10. Gullberg RM, Homann SR, Phair JP. Enterococcal bacteremia: analysis of 75 episodes. Rev Infect Dis 1989;11:74-85.
11. Roca B, Pesudo JV, Gonzalez-Darder JM. Meningitis caused by Enterococcus gallinarum after lumbar drainage of cerebrospinal fluid. Eur J Intern Med 2006;17:298-9.
12. Kurup A, Tee WS, Loo LH, Lin R. Infection of the central nervous system by motile Enterocccus: first case report. J Clin Microbiol 2001;39:820-2.
13. Takayama Y, Sunakawa K, Akahoshi T. Meningitis caused by E. gallinarum in patients with ventriculoperitoneal shunts. J Infect Chemother 2003;9:348-50.
14. LeClercq R, Courvalin P. Resistance to glycopeptides in enterococci. Clin Infect Dis 1997;24:545-56.
15. Navarro F, Courvalin P. Analysis of genes encoding D-alanine-D-alanine ligase-related enzymes in Enterococcus casseliflavus and Enterococcus flavescens. Antimicrob Agents Chemother 1994;38:1788-93.
16. Smith PF, Booker BM, Ogundele AB, Kelchin P. Comparative in vitro activities of daptomycin, linezolid, and quinupristin-dalfopristin against gram-positive bacterial isolates from a large cancer center. Diagn Microbiol Infect Dis 2005;52:255-9.
17. Streit JM, Jones RN, Sader HS. Daptomycin activity and spectrum: a worldwide sample of 6737 clinical gram-positive organisms. J Antimicrob Chemother 2004;53:669-74.
18. Jorgensen JH, Crawford SA, Kelly CC, Patterson JE. In vitro activity of daptomycin against vancomycin-resistant enterococci of various van types and comparison of susceptibility testing methods. Antimicrob Agents Chemother 2003;47:3760-3.
19. Pankey G, Ashcraft D, Patel N. In vitro synergy of daptomycin plus rifampin against Enterococcus faecium resistant to both linezolid and vancomycin. Antimicrob Agents Chemother 2005;49:5166-8.
20. Cubist Pharmaceuticals Inc. Cubicin (daptomycin for injection) package insert. Lexington, MA; 2006.
21. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, document M100-S16, 16th informational supplement. Wayne, PA: Clinical and Laboratory Standards Institute, 2006.